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Improving and accelerating bone repair still are partially unmet needs in bone
regenerative therapies. In this regard, strontium (Sr)-containing bioactive glasses (BGs)
are highly-promising materials to tackle this challenge. The positive impacts of Sr on
the osteogenesis makes it routinely used in the form of strontium ranelate (SR) in the
clinical setting, especially for patients suffering from osteoporosis. Therefore, a large
number of silicate-, borate-, and phosphate-based BGs doped with Sr and produced
in different shapes have been developed and characterized, in order to be used in the
most advanced therapeutic strategies designed for the management of bone defects
and injuries. Although the influence of Sr incorporation in the glass is debated regarding
the obtained physicochemical and mechanical properties, the biological improvements
have been found to be substantial both in vitro and in vivo. In the present study, we
provide a comprehensive overview of Sr-containing glasses along with the current state
of their clinical use. For this purpose, different types of Sr-doped BG systems are
described, including composites, coatings and porous scaffolds, and their applications
are discussed in the light of existing experimental data along with the significant
challenges ahead.
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INTRODUCTION
Bioactive glasses (BGs) are currently used as implantable materials for the management of
various types of bone disorders and diseases (Baino et al., 2018,a; Kargozar et al.,
2019a; Miola et al., 2019). After five decades from the invention of Hench’s 45S5
formulation, numerous commercially- produced BGs are being now used as effective substitute
materials for hard tissue engineering. A few key advantages have been counted for
BGs regarding their application in bone regeneration including the ability to bond
to the living tissues and to improve the growth and proliferation of osteoblasts, the
stimulation of osteogenesis and angiogenesis, and the local induction of antibacterial
and antifungal effects (Kargozar et al., 2017, 2018a, 2019b,c; Mozafari et al., 2019).
The main reason for these abilities is related to the release of various metallic ions
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(e.g., silicate ions, Cu2+) from the glass structure into the
surrounding biological environment (Kargozar et al., 2018b).
Therefore, the researchers incorporate different ions into the
glass structure in order to obtain favorable biological effects.
Indeed, the ionic dissolution products of BGs stimulate the
expression and secretion of biochemical markers involved
in the repair and regeneration of bone such as osteocalcin
(OCN), osteopontin (OPN), and vascular endothelial growth
factor (VEGF) (Jell and Stevens, 2006; Johari et al., 2016;
Kargozar et al., 2019d).
Among the different therapeutic elements, increasing
attention has been paid to add Sr2+ ions to silicate-based glasses
for bone reconstruction application. Strontium (Sr) is an alkaline
earth metal, which normally exists in the human skeleton
(Hodges et al., 1950). This element can be substituted in the
calcium (Ca) positions of apatite with a strong bone-seeking
property (Vaughan, 1975). Sr in the form of strontium ranelate
(SrR) has been used for the treatment of a common bone disease,
i.e., osteoporosis, over the last decades (O’Donnell et al., 2006).
Strontium has also been used in toothpaste to repair decayed
teeth due to its restorative capability (Huang et al., 2016). Sr2+
ions via improving osteoblast activity and inhibiting osteoclast
function can enhance the density of the bone tissue, resulting in
a significant reduction in fracture risk in mammals (Bonnelye
et al., 2008). This increase is supposed to be connected with the
potential of Sr2+ ions to enhance the expression and activity
of osteogenesis-related genes and proteins [e.g., Runx2 and
alkaline phosphatase (ALP)] through the activation of a couple
of cellular signaling pathways (Hurtel-Lemaire et al., 2009;
Peng et al., 2009). Moreover, some researchers have proposed
the immunomodulatory effects of Sr element, which provides
an appropriate environment for enhancing bone regeneration
(Zhang et al., 2016). It was reported that Sr2+ ions might have
antibacterial property when released from different product
formulations (Li et al., 2016; Liu et al., 2016). Having the
above-mentioned characteristics, Sr is being currently used in
various types of glasses (melt-derived and sol-gel) for bone tissue
engineering applications. Moreover, there are several studies in
which Sr-doped BGs have been added to polymeric matrices
for the development of osteoinductive composites in order to
accelerate the bone tissue reconstruction (Kargozar et al., 2018c).
Several formulations of glasses have been developed in which
Ca is partially substituted by Sr. These formulations are presented
as silicate-, phosphate- and borosilicate-based glasses (Lao et al.,
2008; Abou Neel et al., 2009; Pan et al., 2009; Sriranganathan
et al., 2016), which can be produced as fine powders, granules,
fibers, and three-dimensional (3D) scaffolds (Ren et al., 2014;
Kargozar et al., 2016; Yin et al., 2018; Baino et al., 2019).
In the present study, we aim to cover the main aspects around
Sr-containing glass-derived biomaterials that are relevant to
their application in bone tissue engineering strategies. The basic
properties of Sr-doped glasses, such as their physicochemical
characteristics and reactivity upon contact with biological fluids,
are discussed and critically compared in section Sr-containing
BGs: an overview. The use of these materials to prepare cements,
coatings, and composites is described in section Cements,
composites, coatings, and glass-ceramics based on Sr-doped BGs,
while section Three-dimensional (3D) scaffolds is focused on Sr-
based bioactive glass porous scaffolds. The results of in vitro and
in vivo experiments are discussed in section Biological functions
of strontium to show the great importance of Sr as a therapeutic
ion for bone repair and regeneration. In this regard, Sr-regulated
cell signaling pathways involved in osteogenesis induction,
osteoclastogenesis, and bacterial inhibition are presented in
detail to provide a comprehensive picture of the biological
significance of Sr-doped BGs. A concise forecast for future
research is then exposed in section Conclusions and outlook,
just before the Conclusions. In summary, the present study aims
to show a comprehensive view of synthesis methods, structure
and reactivity, and biological outputs of this type of materials
as an updated and focused study for researchers working in the
field. While some general reviews have previously been published
on bioactive glasses, including some contributions oriented to
clinical applications and commercial products (Jones et al., 2016;
Baino, 2017), to the best of the authors’ knowledge this is the
first review paper dealing specifically with Sr-doped BGs and
related biomaterials.
SR-CONTAINING BGs: AN OVERVIEW
Sr-containing BGs have recently attracted much interest among
researchers and scientists due to the positive effects of Sr on
bone metabolism by preventing bone resorption and enhancing
new tissue growth, both in vitro and in vivo (Hoppe et al.,
2011). All these aspects, combined with the well-known features
of BGs (Rahaman et al., 2011), make Sr-containing BGs highly
appealing in the treatment of degenerative bone pathologies (e.g.,
osteoporosis) (Wei et al., 2014; Mao et al., 2017).
Synthesis Methods: Melt-Derived and
Sol-Gel Glasses
According to the specific needs related to the final clinical
application, BGs can be produced either by traditional melt-
quenching route or by sol-gel method, which can confer specific
physical and chemical properties to the material, regardless of the
composition (Fiume et al., 2018). In the past, the sol-gel route was
demonstrated to allow better structural control and homogeneity
of the final material compared to traditional melt-derived glasses.
Moreover, the possibility to obtain a mesoporous structure often
represents an advantage in bone tissue engineering applications
because of the higher specific surface area of the final product
(Zhang et al., 2016), which induces an acceleration of the
hydroxyapatite (HA) formation kinetics on the surface of the
glass by providing more reaction sites for the nucleation of the
crystals (Baino et al., 2018,a).
In a typical melt-quenching approach, the melting of the
reagents is carried out at high temperatures (in the typical
range of 1,300 to 1,550◦C) in electrical furnaces. Adequate
processing parameters (i.e., heating rate and melting time) are
fundamental to obtain a homogeneous and bubble-free melt,
thus guarantying the high quality of the final product. According
to the different desired applications, the melt could be cast
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into molds, quenched in water (“frit”) or drawn into fibers
(Ylanen, 2011; Fagerlund and Hupa, 2016).
Sol-gel process is defined as a chemical-based processing
technique for the production of ceramic materials at noticeably
lower processing temperatures since the polymerization reaction
of a solution containing precursors occurs at room temperature
resulting in the formation of the 3D network, which are properly
chosen in order to tailor the final composition of the system to
the intended purpose (Hench and West, 1990). Briefly, sol-gel
synthesis allows the production of ceramic materials by three
steps: (i) preparation of the precursor solution (sol), (ii) gelation
process of the prepared sol, and (iii) removal of the solvent by
thermal treatments. Doping glasses by the introduction of trace
elements in the sol is relatively easier compared to the traditional
melt-quenching route and allows preserving the bioactivity of
the system while providing a specific therapeutic effect upon
ion release (e.g., angiogenesis, antibacterial and antioxidant
properties) (Owens et al., 2016).
As almost all the BGs compositions, also Sr-doped BGs can
be produced either by melt-quenching route or sol-gel process,
using, respectively, strontium carbonate or strontium nitrate as a
precursor of SrO. Carbonates, in fact, are not of common usage
in the sol-gel process since the temperatures used to stabilize
the network (calcination process) would not be high enough for
allowing the complete removal of undesired carbon residues.
The final products obtained by sol-gel method, including
monoliths, porous scaffolds, fibers, coatings, and granules,
are all characterized by the presence of a mesoporous
texture, which is inherent of sol-gel materials (Owens et al.,
2016; Baino et al., 2018). It is worth mentioning that sol-
gel process was also widely used to synthesize spherical
nanoparticles (Kargozar and Mozafari, 2018; Leite et al.,
2018) to be used as nanocarriers for controlled drug release
for the treatment of bone pathologies, such as osteoporosis
(Fiorilli et al., 2018).
Figure 1 provides a schematic representation of the two
synthesis approaches previously described together with some
examples of final products that could be obtained.
Thermal Properties, Crystallization, and
Sintering Behavior of Sr-doped
Bioactive Glasses
One of the major issues concerning the processing of BGs
to obtain, for example, porous scaffolds, or coatings is the
devitrification, which occurs upon the sintering treatments
required for the densification of the structure. This is an aspect of
concern in tissue engineering applications because the nucleation
of crystalline phases, as well as the specific surface area, are
directly linked to the reactivity of the surface itself and, thus, to
the capability of the material to bond to the host tissue.
As a result, understanding the sintering conditions of glass
powders and how the introduction ofmodifier cations in the glass
network could affect the thermal properties and crystallization
of the materials are among the key aspects to be considered
when choosing a BG to fabricate sintered products for tissue
engineering applications.
When introduced within the glassy matrix as a network
modifier, SrO was found to affect the thermal behavior,
sintering ability, microstructure and crystallization of the
system, depending on both on the synthesis method and on
the composition.
During the last decade, the thermal properties of Sr-
doped bioactive glasses, together with crystallization kinetics
and sinterability have been the object of study of several
research groups.
Sr2+ is often introduced in the glass network as a modifier
cation by partially replacing CaO with SrO. Due to the similar
chemical role played by the two oxides, no significant structural
alterations of the network (Network Connectivity - NC) were
reported, with predominant Q2 silicate structure (Figure 2).
The very similar field strength of Ca2+ and Sr2+ ions
resulted in no significant shielding/de-shielding of the 29Si nuclei
(Fredholm et al., 2010). Anyway, the larger size of the Sr2+ ion
compared to that of Ca2+ was found to expand and weaken the
network, thus leading to a modification of the thermal properties
of the glass (Lotfibakhshaiesh et al., 2010; Goel et al., 2011; Hasan
et al., 2015; Li et al., 2015; Bellucci et al., 2017).
A careful analysis of the currently-available literature suggests
that the effect of the inclusion of Sr on the structural alterations
of BGs is strongly affected by the use of mole or weight
percent in the compositional design. When weight percentage
(wt %) is used, the higher molecular weight (mol%) of
SrO compared to CaO can determine an increase of silica
content in mole percentage, thereby resulting in higher network
connectivity. On the contrary, when the mole percentage is used,
the opposite effect could be observed in melt-derived glasses
(O’donnell and Hill, 2010).
Several thermal studies performed on melt-derived Sr-doped
BGs revealed the possibility to enhance the densification of the
structure upon sintering by increasing the SrO/CaO molar ratio
while preserving the amorphous nature of the system.
DTA analyses performed by Goel et al., for example, reported
no alterations in the glass transition temperature (Tg) and
increased values of the crystallization onset (Tc) and the
crystallization peak (Tp) as a result of the increase in the Sr
content up to 8mol%, resulting in a significantly wider processing
window (PW) of the glass, defined as the difference between the
Tc and the Tg (Goel et al., 2011).
The complete thermal behavior and sintering ability of CaO-
rich silica-based BGs modified by the replacement of CaO
(10mol%) with MgO, SrO or both in a 1:1 ratio was recently
reported by Bellucci et al. (2017). Interestingly, DTA curves
showed lower Tg of the modified glasses compared to that
of the original composition (Bellucci et al., 2017). A similar
outcome was found in another study by Lotfibakhshaiesh
et al. (2010), who attributed the decrease of the Tg to the
expansion of the glass network resulting from the replacement of
Ca with Sr.
On the other hand, the substitution of Sr2+ for Na+, was
found to induce an increase of the Tg from 591 to 760◦C with
(Li et al., 2015), despite no significant changes of the glass
structure were detected by X-ray photoelectron spectroscopy
(XPS), Raman Spectroscopy andMAS-NMR. In fact, even if both
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FIGURE 1 | Schematic representation of (A) melt-quenching and (B) sol-gel route for bioactive glass synthesis and final products.
Sr2+ and Na+ ions act as network modifiers, the increase in
the Tg could be attributed to the different valence of the two
ions. In fact, while Na+ can compensate just one non-bonding
oxygen NBO−, bivalent Sr2+, can charge compensate 2NBO− at
the same time.
One of the major differences between Sr-doped sol-gel
and melt-derived glasses concerns the possibility to retain
the amorphous structure of the material upon sintering. In
sol-gel BGs, XRD analyses revealed that, as the Sr2+ increased
within the composition, the tendency toward crystallization
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FIGURE 2 | 29Si MAS-NMR (A) and FTIR (B) spectra related to glasses with various calcium-to-strontium substitutions. The results reveal no significant effects on
structural properties and network connectivity (Fredholm et al., 2010). *represents spinning sideband.
was more pronounced. In particular, a complete crystalline
structure was observed when CaO was totally substituted by
SrO, with diffraction peaks associated with the Sr2SiO4 phase
(Taherkhani and Moztarzadeh, 2016). The presence of Sr-
containing crystalline phases in sol-gel materials was already
reported by Solgi and coworkers (Solgi et al., 2017), while no
crystallization was observed in melt-derived glasses as a result
of the increase in Sr content (Hill et al., 2004; Fredholm et al.,
2010; Kargozar et al., 2016). In fact, most of the XRD patterns
in melt-derived systems (Hill et al., 2004; Kargozar et al., 2016)
revealed just a slight shift in the amorphous scattering maxima to
lower 2θ-values as a result of the replacement of Ca2+ with Sr2+
ions because of the larger size of the Sr2+ ions than Ca2+ ions
(Kargozar et al., 2016).
However, Massera et al. reported DTA analyses on phosphate
melt-derived glasses (Massera et al., 2013), showed a shift of the
main crystallization peak toward lower temperatures as a result of
the increase of SrOwithin the composition up to 5mol%. For SrO
amounts higher than 10mol%, however, a shift toward higher
temperatures could be observed, and a second crystallization
peak could appear (Massera et al., 2013; Dessou et al., 2017).
Even if a direct comparison between these studies is difficult
to establish due to the different compositions of the systems
investigated, it can be stated that synthesis method indeed plays
a crucial role in defining the physical and thermal properties of
Sr-doped BGs. It is believed that further studies focused on the
direct comparison of equivalent compositions produced by the
traditional melt-quenching route and sol-gel chemical synthesis
would provide a valuable contribution in shedding light on these
peculiar aspects.
Structure and Reactivity of Sr-Doped
Silicate, Borate, and Phosphate Glasses
Achieving highly-controlled ion release from biomaterials is one
of the most important challenges in bone regeneration (Hoppe
et al., 2011). In the last years, BGs have received much attention
because of their interesting capability to promote cell attachment,
proliferation, and differentiation thanks to their dissolution in a
physiological environment based on an ion-release mechanism
(Fiume et al., 2018).
The bioactivity mechanism, proposed for the first time by
Larry Hench, is still accepted for silica-based BGs (Hench,
2006). Upon contact with biological fluids, the formation of
a hydroxycarbonate apatite (HCA) layer is observed on the
material surface, following the crystallization of the amorphous
calcium phosphate film; at the same time, the ionic dissolution
products released from the glass surface (basically calcium and
silicate ions) confers osteogenetic properties to the material,
stimulating the beneficial response of the surrounding tissue,
which culminates in the mineralization of the newly-synthesized
extracellular matrix (ECM) (Hench, 2006; Rahaman et al., 2011;
Jones, 2015).
Probably, one of the most attractive aspects of BGs is the
possibility to tailor their properties by introducing selected
cations able to play a specific functional and/or biological role.
In fact, it has been demonstrated that the addition of such
cations, e.g., Sr2+, into the glass network, affect crystallization
kinetics, crystallinity, and thermal stability of the system to
devitrification, as already discussed in the previous section.
Moreover, the formation of the surface HCA layer, observed
during the bioactive mechanism of glass dissolution, and the
osteogenetic properties were found to be deeply related both to
the type of former oxides and to the presence of dopants.
According to the final application of the material, either
slow or fast dissolution rates might be required. In fact,
while higher dissolution rates are usually associated with
high reactivity and enhanced capability to bond to the host
tissue providing early-stage stability of the implant, it should
be pointed out that having slow dissolution rates of the
material could represent an advantage in those bone-repair
applications characterized by weak metabolic activity typical of
some pathologies, as slower reaction kinetics would be more
suitable in order to match the physiological healing time of
the tissue.
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In the present section, the effect of Sr incorporation within
the glass network of silicate, borate and phosphate glasses will be
discussed by focusing the attention on the structure modification
and the influence on the mechanism of reactivity with biological
fluids (Oudadesse et al., 2011; Li et al., 2014).
Silicate Sr-doped BGs
As regards silicate Sr-doped bioactive glasses, several studies
confirmed that the introduction of Sr as a network modifier
was able to induce important modifications in the bioactivity
rate based on both the composition design (O’donnell and
Hill, 2010) and the synthesis method. pH measurements during
bioactivity tests in SBF and XRD patterns revealed that Sr for
Ca substitution in molar proportions in melt-derived systems
was able to increase both the degradation rate and the apatite-
forming ability of the system because of the expansion of the
glass network determined by the larger dimensions of the Sr2+
ion compared to Ca one (Fredholm et al., 2011). In particular,
Ca release was found to follow a linear trend for Sr substitution
≤10mol%, but an increase of Ca release was observed for Sr
substitution of 2.5mol% because of the larger ionic radius of Sr
element (1.16A) in comparison to Ca (0.94A), which expands
the glass network. XRD pattern was characterized by the presence
of apatite nucleation peaks that become more pronounced as the
Sr content increases, while in the Sr-free control no apatite peaks
were detected (Fredholm et al., 2011).
Interestingly, an opposite behavior was observed in sol-gel
glasses, where the replacement of Sr with Ca in the glass
composition was proved to slow down the formation of the
apatite layer on to the glass surface (Hesaraki et al., 2010a; Lao
et al., 2013). A similar trend was found in sol-gel derived Sr-
containing 13–93 nanoparticles doped with different amounts
of Sr (Hoppe et al., 2014). Interestingly, at the nanoscale,
an inhibitory effect of Sr-doping on the crystallization of the
deposited calcium phosphate layer with respect to the Sr-free 13–
93 nano-BG was observed because of the incorporation of Sr in
the HA layer. This can be supported by Aina et al. (2013) study,
showing a decrease in crystallite size and degree of crystallinity
after introducing Sr into HA due to the larger size of Sr2+ ion
in comparison to Ca, which causes an increase in d-spacing and
crystal cell unit parameters. Therefore, the high local release of
Sr2+ ions facilitated by the high surface area of sol-gel materials
might have led to inhibited HA crystallization. These outcomes
are in line with Rokidi and Koutsoukos’s findings (Rokidi and
Koutsoukos, 2012), showing that the presence of strontium
in supersaturated solutions of calcium phosphate retarded the
crystal growth of both octacalcium phosphate and HA.
Anyway, despite the dissolution rate and HA nucleation
kinetics could be delayed as a result of the increase in Sr content
which can increase the chemical stability of the glass, all the
studies proved the possibility to retain the bioactive potential of
the systems upon Sr-doping in different amounts.
Borate Sr-Doped BGs
Besides silicate BGs, borate systems recently gained increased
scientific interest as attractive materials for several biomedical
applications. Unlike the case of silicon, the coordination number
of boron does not allow the formation of fully three-dimensional
structures, which results, from a chemical viewpoint, in a lower
resistance of network interconnection and hence in higher
degradation rates during contact with body fluids (Wright et al.,
2010). As a result, the cytotoxicity deriving from the rapid release
of boron in the physiological environment has to be carefully
controlled (Balasubramanian et al., 2018). The incorporation of
Sr and other modifiers within the network of borate BGs seems to
be one of the most effective strategies used to face this issue. The
effect of different bivalent modifier oxides (i.e., BaO, SrO, ZnO,
and MgO) on melt-derived borate-based glasses was recently
investigated in a study by Kumari et al. (2017). MgO, SrO and
BaO are conventional modifiers that enter the glass network
by disrupting B–O–B, P–O–P and B–O–P bonds. In particular,
the addition of modifying oxides in borate glasses can augment
the network via the following events: (i) breaking of B–O–B
bonds with the contiguous creation of non-bridging oxygens; (ii)
increasing the oxygen coordination of boron; and (iii) combining
both mechanisms mentioned above (Hasan et al., 2015).
In borosilicate and borate glasses, a slower release of boron
was observed as a result of the increase in strontium content.
The ion movements within the network are, in fact, partially
inhibited by the expansion of the network caused by the larger
size of Sr2+ ion (Pan et al., 2009). Moreover, while Na and B are
easily released into the external environment, SrO uses to form Sr
(OH)2 species, which are chemically more resistant and difficult
to dissolve (Hasan et al., 2015).
Phosphate Sr-doped BGs
Phosphate-based BGs are typically used in those clinical
applications which require high dissolution rates of the implant
(Brow, 2000).
In 2017, Patel and coworkers used Sr/Ca substitution to
control and tune the dissolution behavior of melt-derived
phosphate glasses in the 40P2O5−(16−x)CaO−20Na2O−24
MgO–x SrO system (x= 0, 4, 8, 12, 16mol%) in order to achieve
an accurate control on the rate of release of therapeutic ions
included within the glass composition. The initial addition of SrO
into the glass composition (up to 4mol%) resulted in a decrease
of the dissolution rate of the glass, thus suggesting an increase of
the cross-linking between phosphate chains (Patel et al., 2017).
Kapoor and coworkers studied the structure-properties
relationships in different melt-derived alkali-free phospho-
silicate glass compositions co-doped with Zn2+ and Sr2+ ions
(Kapoor et al., 2014). In particular, the attention was focused on
the co-doping effects of Sr and Zn on the chemical dissolution
behavior and bioactivemechanism in SBF. No effect of the Zn/Mg
and Ca/Sr substitution was observed on the NC, which remained
constant at about 1.95. Despite the lower NC compared to that of
commercial 45S5 Bioglass R©, the system showed lower solubility
as a result of the ionic field strength associated with its constituent
ions. There was a significant difference in the leaching of Zn2+
and Sr2+ ions in SBF and Tris-HCl despite equimolar ZnO,
and SrO concentrations were incorporated, with a higher rate of
release for Sr (Kapoor et al., 2014).
Phosphate glass properties make them very appealing as
basic materials for the production of resorbable implants. In
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TABLE 1 | Comparison among the Sr-doped glass systems discussed in the section Sr-containing BGs: an overview.
Glass system Synthesis method/
former oxide
The object of the study Thermal and structural properties Bioactivity tests References
Na2O/K2O/MgO/CaO/B2O3
SiO2/P2O5/SrO
M/B Controlled release of borate and Sr2+ ions for
new bone formation
-No crystallization upon doping
-No changes in the glass structure
-Complete conversion to apatite
-Controlled degradation and ion release
below the cytotoxic level
Li et al., 2016
CaO/SrO/SiO2/MgO/P2O5
/CaF2
M/S Effect of Sr for Ca substitution on structural
features, sintering behavior, and
apatite-forming ability
- No changes in the glass structure
- Wider PW up to 10 SrO mol%
-Lower apatite-forming ability in SBF
- Lower chemical degradation in TRIS-HCl
-Ion release within therapeutically
effective range
Kargozar et al.,
2016
Na2O/SrO/SiO2/TiO2/CaO M/S Influence of Na
+ and Sr2+ on solubility - No changes in the glass structure
- Higher Tg
- Lower ion release rates Ren et al., 2014
B2O3/SrO/TiO2
B2O3/SrO/Na2O/TiO2
M/B Production of a borate glass system without
the addition of other network formers;
assessment of the physical, structural,
thermal, and biological properties
-Higher Tg
-Higher glass density
- SrO content influences degradation rate
and ion release
-Sr concentration above cytotoxicity levels
Yin et al., 2018
CaO/SrO/SiO2/P2O5/Na2O M/S Influence of Sr for Ca substitution on physical
properties
- No changes in the glass structure
- Higher glass density
- Lower oxygen density (network expansion)
- Lower dilatometric softening point
- Higher thermal expansion coefficient
- Lower Tg
_ Baino et al., 2019
CaO/
SrO-MgO/SiO2/Na2O
K2O/P2O5
M/S Combination of the thermal behavior of
Ca-rich silicate glasses with an improvement
in biological results of MgO- and SrO-modified
glasses
- Improved thermal stability
- Improved mechanical properties
- Strong apatite-forming ability Jones et al., 2016
CaO/SrO/SiO2/MgO/Na2O
K2O/ZnO/P2O5
M/S Influence of Sr/Ca substitution on the sintering
behavior
- Lower Tg
- Higher Tc
- Wider PW
_ Baino, 2017
SiO2/CaO/SrO SG/S Development of Sr-delivering glasses - No alterations in the mesoporous texture - Enhanced bioactivity
- Increased reaction kinetic
Wei et al., 2014
SiO2/CaO/MgO/SrO SG/S Synthesis, characterization, and investigation
of the apatite-forming ability in SBF
- Crystalline phases (calcium and strontium
silicates)
- Good apatite-forming ability
- Apatite layer after 3-5 days immersion
in SBF
Fiume et al., 2018
CaO/SrO/P2O5/
Na2/CaO/SrO
M/P Glass fiber production - Higher thermal stability
- Wider PW
Reduced phosphate ions release
- Formation of the apatite layer
- SrO and MgO embedded in the apatite
layer
- Improved chemical stability
Baino et al.,
2018,a
P2O5/CaO/SrO/Na2O/MgO
SrO
M/P Investigation of phosphate glass formulation
for controlled Sr release
- Lower Tg and Tm
- Broadening of the main crystallization peak
- No changes in the glass structure
- Higher chemical durability
- Lower dissolution rates
Hench, 2006
SiO2/P2O5/CaO/SrO SG/S-P Production and characterization of Sr-doped
silico-phosphate glasses
- Higher Tp
- Nucleation of new crystalline phases
- Increase in the gel viscosity
- Higher biodegradation rate Hesaraki et al.,
2010b
M,Melt-quenching route; SG, Sol-gel route; S, Silicate glasses; B, Borate glasses; P, Phosphate glasses; PW, Processing Window; Tg, Glass transition temperature; Tc, Crystallization onset temperature; Tp, Maximum rate of crystallization
temperature; Tm, Melting temperature; SBF, Simulated body fluid. All the results are referred to the doped system, compared to the undoped one. If the effect of SrO replacement for another oxide is specifically investigated, the oxide
couple (e.g., SrO/CaO) is indicated in the column “Glass system.”
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this attempt, melt-derived Sr-containing polyphosphate glasses
doped with Mg and Ti were investigated by Weiss et al. (2014).
The inclusion of Mg and Ti was found to increase the bonding
strength between phosphate chains resulting in a higher glass
stiffness, better mechanical properties, and lower degradation
rates in Tris-HCl solution. The HA layer observed after 15 days of
immersion in SBF was thicker and denser for the doped systems,
thus suggesting a stimulatory and synergic effect of multiple ions
on the bioactivity mechanism of the glass (Weiss et al., 2014).
Interestingly, some studies demonstrated that the
improvement in the chemical stability of phosphate glasses
seems to be not affected by the thermal properties (Hesaraki
et al., 2010b; Stefanic et al., 2018).
Stefanic et al. investigated the effect of Sr substitution in
40P2O5-25CaO−5Na2O–(30 – x) MgO–xSrO systems (x= 0,
1, 5, 10mol%). FTIR analysis revealed no significant structural
modifications with no variations in the O/P ratio and the
Q speciation. However, phosphate bands shifted toward lower
wavenumbers as the Sr content increased from 1 to 10mol%.
This shift could be attributed to the lower field strength of Sr2+
ions, which have higher atomic number compared to that of
Mg2+ ions, as the total divalent cation-to-phosphate ratio did
not change within all the glasses investigated. Despite the higher
thermal stability of the Sr-free system, the chemical durability
of these melt-derived glasses in water was found to decrease
with decreasing Sr content, and it was characterized by linear
degradation and highly controllable profiles (Stefanic et al., 2018).
Comparative Remarks
Table 1 provides a summary of the literature results discussed
in the previous sections and relates thermal and structural
properties to the bioactive potential of the systems analyzed. In
summary, it can be stated that there is a strong dependence
on the basic compositional system, and some peculiar trends
can be observed. While Sr doping in silicate glasses was found
to enhance the mechanism of bioactivity and accelerate the
ion release rates, the increase of SrO in borate and phosphate
systems typically led to improved chemical stability of the
material. However, it is worth pointing out the presence of
some exceptional cases (reported in Table E1) that suggest
caution in generalizing the results. In fact, a direct comparison
between different systems is hard to carry out since all the
properties of glasses are affected by multiple factors that
simultaneously contribute to the final and complete behavior of
the examined material.
Atomistic Simulations
Understanding the relationship that exists between glass
structure and functional properties is not always immediate,
especially when the design of the glass composition becomes
complex and rich of different elements whose effects are the result
of the interaction of multiple factors.
In this section, atomistic simulations will be presented
as a valuable instrument aimed at rationally designing
glass compositions in order to define, investigate and
better understand the structure, dissolution, and bioactivity
mechanisms of glasses used in biomedical applications thanks to
FIGURE 3 | Diffusion pathways suggested for atoms of Na (green ball), Ca
(blue ball), and Sr (pink ball). The other elements are depicted as Si (small
yellow ball), P (small purple ball), O (small red ball) (Du and Xiang, 2012).
the rapid increase in computing power and development of new
algorithms and methodologies (Tilocca, 2010; Xiang and Du,
2011; Du and Xiang, 2012).
Molecular dynamics (MD) simulations are currently the most
widely used method that allows very accurate and reliable
glass structural models to be generated. Experimental studies
showed that Sr-containing BGs, especially in the case of SrO/CaO
substitution, did not exhibit very large modifications in terms
of glass structure because of the similarity of Sr2+ and Ca2+
ions from a chemical viewpoint. Apart from these preliminary
considerations, MD simulations were indeed useful to define the
local environment and the diffusion behavior of SrO containing
BGs (Xiang and Du, 2011; Du and Xiang, 2012; Xiang et al.,
2013). The effects of SrO/CaO substitution on glass diffusion and
bioactivity was deeply investigated by Du and Xiang (2012), Du
and Xiang (2016) on three different compositions characterized
by a silica content ranging from 46 to 65mol% to cover multiple
bioactivity levels (Du and Xiang, 2016). The local environment
around modifiers cations, as well as network connectivity, were
determined as a function of the glass composition. Figure 3
shows the diffusion pathways of Na, Ca, and Sr obtained by
MD simulations.
Sodium ions were found to have a higher diffusion coefficient
and lower energy barriers compared to Ca2+ and Sr2+ ions.
Interestingly, an increase in silica content led to a decrease in the
diffusion coefficient of the modifiers cations.
Because of the similarities of the self-diffusion coefficients
and energy barriers of Sr2+ and Ca2+, Du and Xiang suggested
that it is actually possible to maintain almost unaltered the basic
physicochemical properties of the starting glass composition
while enhancing tissue growth due to the release of Sr2+ ions (Du
and Xiang, 2016).
While in classical MD simulations the interatomic forces
are approximated by an empirical potential, easier to compute
but affected by the introduction of approximations and loss
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of information on the electronic structure, in a recent study
(Christie and de Leeuw, 2017). They investigated the effect of Sr
addition on the bioactivity of phosphate glasses by developing a
new interatomic potential able to consider the polarizability of
oxygen ions in order to investigate the medium-range structure,
which is responsible for the bioactivity mechanism. Several Sr-
containing glass compositions were simulated by both classical
and first-principle MD. In general, it was confirmed that Sr
incorporation caused minimal changes in the dissolution of
the glass, and the bioactivity remains preserved. The NC and
Qn distribution were shown to be essentially unaffected by the
incorporation of Sr. The first result was to be expected, as the
network connectivity depends on the ratio of the number of
oxygen atoms to the number of phosphorus atoms, which does
not change for SrO/CaO or SrO/Na2O substitutions. The Qn
distribution might change, but the amounts of Sr incorporated
in the studied compositions were relatively small (10mol%max.)
and, thus, the associated change was small, too (Christie and
de Leeuw, 2017).
CEMENTS, COMPOSITES, COATINGS,
AND GLASS-CERAMICS BASED ON
SR-DOPED BGS
The majority of the BGs form a strong interfacial bond with
the bone (Hench, 2013). An initial investigation by Piotrowski
et al. (1975) proved that the interfacial bond between 45S5
Bioglass R© and cortical bone in rat and monkey models is equal
to or even higher than the strength of the host bone (Piotrowski
et al., 1975), and this finding was eventually confirmed clinically
(Montazerian and Zanotto, 2017a). As summarized in the
previous section, many Sr-doped BGs have excellent biochemical
compatibility; however, they have some limitations from a
biomechanical viewpoint. The bending strength and fracture
toughness of most of the compositions discussed above are in
the range of 40–60 MPa and 0.5–1 MPa m1/2, respectively.
These values are <50–150 MPa and 2–12 MPa m1/2, which
are the typical ranges of cortical bone (Hench, 1991), and thus
make Sr-doped BGs inappropriate for load-bearing applications.
However, for some applications, low strength and fracture
toughness are offset by the low elastic modulus of the glass (30–
35 GPa), which is close to that of cortical bone (7–30 GPa).
Therefore, the low strength does not question the usefulness of
Sr-doped BGs for several important applications like cements,
composites, and coatings. Low strength also does not affect the
application of BGs as buried, low-loaded and compressively
loaded implants, or in the form of powders and a bioactive phase
in bone cements. Thus, several Sr-doped BGs were considered for
the development of coating or composite to expand their range
of applications. Furthermore, the development of glass-ceramics
(GCs) provides another option for improving the mechanical
properties of BGs.
Bone Cements
Conventional polymeric bone cements like poly(methyl
methacrylate) (PMMA) and glass ionomer cements are among
the most used materials in dentistry and orthopedics, but
they have numerous drawbacks. They commonly show poor
bonding with bone, a high exothermic reaction in situ, low
mechanical reliability, and inadequate radiopacity. Moreover,
the high-temperature or elaborated processing techniques, slow
degradation rate, and low strength are other limitations of
commercial ceramic bone cements such as calcium phosphate
cement (CPC) and HA (Kenny and Buggy, 2003). Therefore, the
objective of numerous studies was to develop and characterize
bone cements composed of reinforcing components like Sr-
doped BG particles that serve as the reinforcing and radiopaque
phase in polymers or sintering aid in ceramics. In addition,
the Sr-doped BGs are usually selected due to their outstanding
characteristics, including bioactivity, osteogenic potential, and
the capability of the controlled release of Sr2+ ions.
A Sr-doped HA bone cement was prepared to enhance
bioactivity and biocompatibility. The release of Sr2+ ions
was supposed to the main reason for promoted osteoblast
proliferation, which could facilitate the precipitation of newly-
formed HA and resulting in the enhanced strength of the bone-
cement interface (Cheung et al., 2005; Ni et al., 2006).
The preparation of an injectable Sr-containing CPC has
been successfully reported with promising properties, including
setting time, compressive strength, and radiopacity (Yu et al.,
2009). This cement could improve the proliferation and
differentiation of both osteoblastic cells and human bonemarrow
mesenchymal stem cells (hBMSCs) in vitro (Kuang et al., 2012;
Schumacher et al., 2013) and the new bone formation was
accelerated at the bone-cement interface, as well as in the
entire metaphyseal fracture defect site in ovariectomized rats
(Thormann et al., 2013).
Sr-BGs in Ionomer Cements
Starting from 2008, glass polyalkenoate cements (GPCs), used
for restorative purposes in dentistry and orthopedics, were the
subject of extensive research by Boyd et al. (2008), Wren et al.
(2008), Clarkin et al. (2009), Wren et al. (2010), Wren et al.
(2013). They employed new SiO2-ZnO–CaO–SrO glasses instead
of the commercial fluoro-aluminosilicate glass. The glass usually
reacts with an aqueous portion of the cement such as polyacrylic
acid (PAA). The degradation of the glass structure is regulated
by PAA, leading to the release of metallic cations into the
aqueous phase of the setting cement. The carboxylate groups
cross-link these cations on the PAA chains; embedding reacted
and unreacted glass particles in a hydrated polysalt matrix of
the cement (Boyd et al., 2008; Wren et al., 2008, 2010, 2013;
Clarkin et al., 2009).
Different from aluminum as a neurotoxin, zinc is expected to
inference positively the proper functioning of the immune system
and to impart antibacterial properties to the cement (Kargozar
et al., 2018a). Sr2+ ions were substituted with Ca2+ in the glass
because their ionic radii are similar. Furthermore, strontium
was known to have a lot of beneficial effects on bone, to share
some of the same physiological pathways as Ca and to improve
the radiopacity.
Boyd et al. (2008) produced GPCs from 48SiO2−36ZnO–
(16-x)CaO–xSrO (x = 0, 4, 8, and 12mol%) glasses and PAA.
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Glass frits were prepared via the conventional method ofmelting-
quenching in water. They prepared the cements by thoroughly
mixing 2 g of glass (particle sizes < 45µm) with 0.6 g of PAA
powders and 0.9mL of distilled water on a glass plate. Thorough
mixing of cements was undertaken during 30 s. The results
reported in this research indicated that the replacement of Ca
with Sr in the glasses has no significant influence on the structure
of the studied glasses, as proved by the trivial effect that the
replacement had on Tg and NMR-derived Qn distributions of
each glass. Nonetheless, it was stated that increasing substitution
of Ca with Sr increased the setting times, which was ascribable
to the higher basicity of SrO over CaO. Wren et al. (2008)
reported 29 and 110 s as the maximum working time and setting
time, respectively; which was inadequate for clinical procedures.
Sufficient working and setting times were expected to reach 6–10
and 15min, respectively. However, the optimum biaxial flexural
and compressive strength reached 34 and 75 MPa, respectively,
proving that these materials could be potentially used in load-
bearing applications. The in vitro evaluation in SBF showed that
all the prepared cements could promote the development of
amorphous calcium phosphate at their surface after 1 day of
incubation. This event became more apparent (increased density
and coverage) over time, representing that these cements could
bond to bone directly (Wren et al., 2008).
In line with these researches, Clarkin et al. (2009), Clarkin
et al. (2010) employed 4SrO−12CaO−36ZnO−48SiO2 (mol%)
glass, low molecular weight PAA and a modifying agent,
trisodium citrate dihydrate (TSC), to optimize working and
setting times which were too short for invasive surgical
procedures, including bone fracture fixation and void filling.
In their study, the newly-formulated GPC was compared with
HydrosetTM, a commercial self-setting CPC. They compared
compressive strength, flexural strength, Young’s modulus,
working and setting times, and injectability. The formulation had
higher mechanical strength (39 MPa in compression) than both
vertebral bone (18.4 MPa) and HydrosetTM (14 MPa). However,
the working time (2min compared to ∼4min for HydrosetTM)
and rheological properties of the cement, although improved,
still required further modifications before their application
in minimally invasive surgery, e.g., vertebroplasty or luting
applications (Clarkin et al., 2009, 2010).
In their endeavor to adjust the working and setting times
of their promising cementitious composites, Wren et al.
(2010) added some naturally-derived proteins/polymers to
the zinc-containing glass polyalkenoate cements (GPCs). The
authors used chitin (Chi.), collagen (Col.), cysteine (Cys.),
and keratin (Ker.). They concluded that the addition of
these proteins/polymers could lead to little change to the
working and setting times, and even the compressive strength
was found to decrease slightly. No significant difference was
observed in the flexural test. The same GPC containing
4SrO−12CaO−36ZnO−48SiO2 (mol%) glass, named Zn-GPC,
was compared to commercial materials (Fuji IX and KetacMolar)
which have setting chemistry comparable to Zn-GPCs. Working
and setting times (handling properties) for Zn-GPCswere shorter
than the commercial materials. Zn-GPCs also had a higher setting
exotherm (34◦C) than the commercial products (29◦C). The
maximum compressive strength for Zn-GPC, Ketac Molar and
Fuji IX was 75, 216, and 238 MPa, and biaxial flexural strength
was 34, 62, and 54 MPa, respectively. Based on the results of
compressive strength test, Zn-GPCs have appeared to be more
appropriate for spinal applications in comparison to commercial
GPCs but the characteristic times for surgical handling still need
optimization (Clarkin et al., 2010; Wren et al., 2013).
Sr-BGs in Calcium Phosphate Cements (CPCs)
In 2016, Kent et al. (2016) developed a kind of CPCs by reacting
BGs with Ca(H2PO4)2 to form cement. They found that a P2O5
content of 4 mol% or greater is required in SiO2−P2O5−CaO–
Na2O glass to produce cement. The phases formed depend on
glass composition; brushite (CaHPO4·2H2O) and octacalcium
phosphate (Ca8H2(PO4)6·5H2O, OCP) form first with 6 mol%
P2O5 in the glass. Brushite dissolves, reforms as OCP and then
transforms to apatite. These new cements offer a new route to
forming CPCs that combine in situ setting and injectability of
“conventional” CPCs with resorbability and bioactivity of BGs.
D’Onofrio et al. (2016) designed and synthesized a series of Sr-
doped BGs to add them in a range of CPCs. They aimed to
synthesize, as the final product of the cement, Sr-containing HA
and investigated the effects of Sr2+ ions on the physicochemical
properties of the cement. Glasses in the 42SiO2−4P2O5−(39-
x)CaO−15Na2O–xSrO (mol%) system were synthesized by
progressively replacement of Sr with Ca (x = 1.95, 3.90, 9.75,
19.5, 29.25, 39%). Sr-doped CPCs were developed by mixing
the glass and Ca(H2PO4)2 powders with a 2.5% solution of
Na2HPO4. Setting time and compressive strength were measured
at 1 h, 1 day, 7 and 28 days post-incubation in Tris buffer
solution. XRD, FTIR, and radiopacity were measured, too, and
crystal morphology was assessed by SEM. Sr substitution in
the glass increased setting time up to 25%, while its higher
substitutions acted oppositely and resulted in a decrease in the
setting time. Compressive strength reached 12.5 MPa because of
the interlocking morphology of the crystals. XRD showed that
Sr influenced the type of crystal phases formed. Octacalcium
phosphate was the main phase present after 1 h and 1 day while
after 28 days OCP was completely transformed to Sr-containing
HA (SrxCa(10-x)(PO4)6(OH)2, Sr-HA). Radiopacity enhanced
proportionally to Sr substitution in the glass network. This study
introduces a novel method regarding the development of a bone
graft forming in vitro Sr-HA as a final product by applying a Sr-
BG as a precursor, and the authors claimed that the prepared
injectable cements are promising candidates for orthopedic and
dental applications.
Sr-doped BGs in Polymeric Cements
Sr-doped BG particles are added in polymeric cements
as a bioactive, reinforcing or radiopaque phase. In this
regard, Zhang et al. (2015) proposed a new injectable
cement composed of Sr-doped borate BG particles
(5.5Na2O−7.34K2O−7.34MgO−20.18CaO−49.54B2O3−1.83
P2O5−8.27SrO in mol%) and a chitosan-based bonding phase.
The glass was prepared by the conventional melt-quenching
route and ground to form particles of <40µm. The authors
prepared the hardening phase via mixing chitosan with a
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 10 July 2019 | Volume 7 | Article 161
Kargozar et al. Strontium Bioactive Glasses Bone Regeneration
β-glycerophosphate at a ratio of 7:1 by volume. In addition, they
prepared the cement paste by mixing the glass particles with
the hardening liquid at a ratio of 2.0 g/mL. The BGs stimulated
the bioactivity, conversion to HA, and the ability to encourage
osteogenesis, whereas the chitosan provided an interconnected
biodegradable and biocompatible bonding component. The
cement set in situ after the initial setting time of 11.6 ± 1.2min)
and represented a compressive strength of 19 ± 1 MPa. The
proliferation and differentiation of hBMSCs treated with the
cement were significantly higher than the cells incubated with
a similar cement made of chitosan-bonded Sr-free borate BG
particles. The osteogenic capacity of the cement was shown
by micro-computed tomography (micro-CT) and histology
of the samples obtained from critical-sized rabbit femoral
condyle defects treated with the material. The results showed
newly-formed bone at different distances from the implants
after 8 weeks. Moreover, the index of bone-implant contact
was considerably higher for the implant containing Sr-doped
glass compared to the implant with Sr-free glass particles.
Overall, the results indicated that this Sr-containing cement
could be considered as a promising substitute for the repair and
regeneration of irregularly-shaped bone defects with the use of
minimally invasive surgery (Zhang et al., 2015).
Cui et al. (2017) added another Sr-containing borate
BG as the reinforcing and bioactive filler to PMMA
cement. The PMMA cement and Sr-BG/PMMA composites
were prepared by mixing solid and liquid components
at particular solid-to-liquid ratios. The solid part of
composite cement contained Sr-doped BG (10–50µm) and
PMMA (10–80µm) particles. The glass composition was
6Na2O−8K2O−8MgO−16CaO−6SrO−27B2O3−27SiO2−2
P2O5 (mol%) and prepared by the melting-casting method. The
glass and PMMA solid powders were mixed with the liquid
component containing 3mL of MMA monomer and 0.14 µl
DMPT accelerator. Detailed compositions of the PMMA cement
and Sr-BG/PMMA composite cements are summarized in
Table 2 (Cui et al., 2017). Figure 4 shows the microstructure of
the PMMA cement and 10Sr-BG/PMMA and 30Sr-BG/PMMA
composite cements. The Sr-doped glass powders adhered to the
PMMAmatrix (Figures 4B,C), and there were some pores within
the Sr-BG/PMMA composite cements. Elemental mapping by
energy dispersive spectroscopy (EDS) (Figures 4D,E) revealed a
homogeneous distribution of silicon and calcium – and hence of
glass particles – within the PMMAmatrix (Cui et al., 2017).
The exothermic polymerization temperature significantly
decreased after using Sr-BG/PMMA composite cements
compared with BG-free PMMA while the suitable setting time
and high mechanical strength were retained. The Sr-BG/PMMA
composites were bioactive in vitro and released B, Ca, and P
ions into SBF. The addition of Sr-doped BG promoted the
adhesion, proliferation, migration, and collagen secretion
of MC3T3-E1 cells in vitro. Moreover, in vivo investigation
revealed that Sr-BG/PMMA composite cements were better
osseointegrated than BG-free PMMA bone cement. Sr-doped BG
in the composite cement could enhance new bone formation in
rat tibia defects around the cement-bone interface after 8 and 12
weeks post-implantation (Figure 5), while conventional PMMA
TABLE 2 | Compositions of PMMA cement and related Sr-BG/PMMA cements
(Cui et al., 2017).
Cements Filler loading
(wt%)
Solid parts (g) Liquid
parts (mL)
S/L
(S = PMMA
+ SrBG)
PMMA
powder
(g)
Sr-BG (g)
Control
(PMMA)
0 2 0 1 2: 1
10Sr-
BG/PMMA
10 2 0.2 1 2.2: 1
20Sr-
BG/PMMA
20 2 0.4 1 2.4: 1
30Sr-
BG/PMMA
30 2 0.6 1 2.6: 1
could only stimulate the formation of an intervening connective
tissue layer. As a result, the Sr-BG/PMMA composite cement
was recommended as a substitute to PMMA bone cement in
clinical orthopedic applications and minimally invasive surgery
(Cui et al., 2017).
In order to improve visualization by radiography during
surgery, radiopacifying agents such as barium sulfate (Ba2SO4)
or zirconium dioxide (ZrO2) are added to cements. These
materials may deteriorate the biocompatibility of the cements
or have detrimental influences, such as bone resorption, and
degradation of mechanical properties (Bhambri and Gilbertson,
1995; Sabokbar et al., 1997; Demian and McDermott, 1998;
Wang et al., 2005). However, incorporating bioactive and
biocompatibility radiopacifier agents would have beneficial
effects. Bioactive radiopaque glasses containing heavy elements
such as Sr (Boyd et al., 2009), niobium (Nb) (Bauer et al.,
2016), and zirconium (Zr) (Tallia et al., 2014; Montazerian et al.,
2015; Montazerian and Zanotto, 2016), known to have positive
and therapeutic influences on bone, have attracted the attention
of the researchers nowadays. Therefore, O’Brien et al. (2010)
incrementally replaced Ba2SO4 in the commercial Spineplex R©
cement with a Sr-containing radiopaque glass composition
(40SiO2−30Na2O−20SrO−10CaO in mol%). The substitution
increased the setting time from 13.1min for Spineplex R© to
16.6–18.3min for the new cements. A reduction in the peak
exotherm during curing (23◦C) was observed for Spineplex R©
in comparison to the fully replaced cement, demonstrating that
reduced thermal necrosis in the in vivo setting is achievable
using these materials. No significant deterioration was recorded
regarding Young’s modulus and compressive strength of each
formulation due to the addition of Sr-doped BG. Although the
radiopacity of the new cements was decreased up to 18% relative
to the control, but still maintained radiopacity equal to several
millimeters of aluminum (O’Brien et al., 2010).
More recently, Goñi et al. (2018) prepared different composite
bone cements comprising PMMA beads and particles of gel-
derived SiO2-CaO–P2O5 BGs with 0-20 wt% of CaO substituted
with SrO (Mendez et al., 2004). The difference between the
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FIGURE 4 | The microstructure of (A) PMMA bone cement, (B) 10Sr-BG/PMMA and (C) 30Sr-BG/PMMA composite cements (the black arrows indicate the
Sr-doped BG particles). EDS mapping of the elements (D) Si and (E) Ca shows that Sr-BG particles are well-dispersed in the 30Sr-BG/PMMA composite cement
[Adapted from Cui et al. (2017) with permission from The Royal Society].
cementitious materials was in the Sr content of BG and relative
amounts of the solid phase. The aimwas to determine the effect of
the mixture of solid phase constituents on maximum exothermic
temperature, setting time, and injectability. Regarding the
obtained results, they stated that composite formulations have
improved performance than that of PMMA the reference
(PMMA), with lower exotherm temperature and setting time
and higher injectability. The same authors showed that
incorporation of Sr-substituted BGs into these materials
conferred bioactive properties linked to the role of Sr in
bone formation, introducing some composite cements that may
be appropriate for application in percutaneous vertebroplasty
(Goñi et al., 2018).
Bone Graft Ceramic/Polymeric Composites
Calcium phosphate-based ceramics, e.g., HA and β-tricalcium
phosphate (β-TCP), have been extensively using in dental and
orthopedic applications since the 1980s (Bohner, 2000), primarily
due to their similarity (crystal and chemical properties) to the
mineral component of the bone tissue. The supportive role
of calcium phosphates regarding adhesion, proliferation, and
the differentiation of MSCs and osteoblasts is previously well-
documented (Kamitakahara et al., 2008). HA and TCP are
both highly osteoconductive and biocompatible. Although HA
and TCP are recognized as biocompatible and osteoconductive
materials, they suffer from some limitations, such as brittleness
and poor mechanical properties. Therefore, a large number
of attempts have been made to enhance their mechanical
strength, like the addition of a sintering aid to increase the
density and minimize the residual porosity of the system.
Most of these studies employed BGs and, in particular,
45S5 Bioglass R© (Goller et al., 2003) and a CaO-rich BG
formulation (2.3K2O−2.3Na2O−45.6CaO−2.6P2O5−47.3SiO2
in mol%) that is reluctant to crystallization (Bellucci et al., 2014).
Additionally, there is proof of the positive effects of the presence
of Sr in these materials. To test the influence of the addition of Sr-
doped BGs to produce composites, Hesaraki et al. (2012) added
different amounts of sol-gel derived Sr-containing BG nano-
powders (26CaO−5SrO−5P2O5−64SiO2 wt.%) to HA with a
mean particle size of 0.5µm to improve its mechanical properties
after sintering. The samples were sintered at 1,000–1,200◦C. A
couple of physicochemical and biological assays, including XRD,
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FIGURE 5 | Micro-CT evaluation of bone regeneration in the rat tibia defects after implantation of PMMA and 30Sr-BG/PMMA composite cements. The 3D
reconstructed sagittal images of the area surrounding the cement implants show new bone formation around the cement-host bone interface at (A) 8 and (B) 12
weeks (area outlined in red); (C) BV/TV (bone volume/total volume) in the defects implanted with 30SrBG/PMMA composite cement for different post-implantation
times. Values are presented as mean ± s.d.; n = 3. *Significant difference between groups (p < 0.05) [Adapted from Cui et al. (2017) with permission from The Royal
Society].
SEM, microindentation, MTT, and ALP assay were carried out
by the authors to characterize the samples. The obtained results
showed that the inclusion of 1–10% of BG nano-powder led to the
formation of β-TCP phase, the content of which increased with
increasing the amount of Sr-BG and temperature. In addition to
β-TCP, α-TCP, and calcium phosphate silicate were also found in
the composition of HA sintered with 10% glass. After sintering
at 1,200◦C, bending strength (∼70 MPa), microhardness (∼300
HV) and fracture toughness (∼1.2 MPa.m1/2) improved by
adding 1–5% Sr-BGs, whereas these mechanical properties
decreased when 10% glass was added. The addition of nano-sized
Sr-BGs did not alter the rate of cell proliferation but increased
the level of ALP produced (Hesaraki et al., 2012). The same
gel-derived Sr-BG was added to biphasic calcium phosphate
(BCP) by Nezafati et al. (2014), who sintered the mixture at
1,100, 1,200, and 1,300◦C. The maximum bending strength (45
MPa) was achieved when BCP was added with 3 wt% Sr-BGs
and sintered at 1,200◦C. The addition of Sr-BGs did not affect
the phase composition of BCP when it was treated at 1,200◦C,
and the composite supported the adhesion and expansion of rat
calvarium-derived osteoblasts.
Sr-containing phosphate-based glass
(45P2O5−32SrO−23Na2O in wt%) was also used as a sintering
aid for β-TCP, which was heat-treated at 1,250◦C (He and
Tian, 2018). The results showed that the glass addition allowed
liquid-phase sintering of β-TCP with the noticeable promotion
of densification (He and Tian, 2018). In the sintering process,
the Sr-doped BG reacted with β-TCP, and the Sr+2 ions
replaced Ca2+ ions of β-TCP. Furthermore, the glass addition
efficiently hindered the transformation of β-TCP to α-TCP. The
compressive strength of these porous β-TCP-based bioceramics
was improved from 7 to 11 MPa by introducing 10 wt%
Sr-doped BGs.
It has also been proved in several other studies that Sr-
substituted TCP and HA cements/ceramics show promise for use
in orthopedic, e.g., in filling bone defects (Kim et al., 2004; Saint-
Jean et al., 2005; Pina et al., 2010). More recently, Kuda et al.
(2018) have prepared composite materials by adding 1 wt% SrO
to biogenic HA (BHA) and sodium borosilicate glass in a ratio
of 50/50 by weight. The composites were sintered at 780◦C for
1 h. The BG addition improved the sinterability, while the crystal
lattice constant of biogenic HA decreased. It was also found that
such BHA/glass/SrO composite possessed a higher porosity and
rate of dissolution in a physiologic solution, which make it highly
attractive for use in the replacement of defective areas of bone
(Kuda et al., 2018).
Other promising applications of Sr-doped BGs are addressed
to the repair of alveolar bone in dentistry. Polymeric membranes
are one of the extensively used materials in periodontology and
dental implantology, which improve the bone healing process
in the method of guided bone regeneration (GBR) (Misra et al.,
2006). The standard rule of this treatment is to physically provide
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FIGURE 6 | SEM micrographs of electrospun composites made of (A) and (B) poly(caprolactone) (PCL); (C) and (D) PCL and particles of Sr-containing BG. The white
arrows indicate that BG particles are embedded in the polymeric electrospun fibers [Adapted from Santocildes-Romero et al. (2016), after permission by Wiley
and Sons].
a relatively remote environment where bone can repair via
keeping out local soft tissues from a defect site. An ideal barrier
membrane should resorb and stimulate bone tissue regeneration
within the defect (Misra et al., 2006). The prospective of
electrospinning (Agarwal et al., 2008) and advantages of Sr-
substituted BGs have been discussed for this purpose, and
it is expected that the combination of these two approaches
results in the fabrication of potent membranes in terms of bone
tissue regeneration. Ren et al. (2014) combined melt-electrospun
polycaprolactone (PCL) with Sr-containing 45S5 BG to prepare
composite scaffolds. They did not include 45S5 BG as reference
material, so it was uncertain whether the final device benefitted
from the substitution of Ca with Sr. Furthermore, Ren et al.
(2014) reported the diameter of the fibers in the range of
several tens of micrometers as a result of electrospinning of
melt. It has been stated that fibers with smaller diameters (a few
micrometers to hundreds of nanometers) are more favored for
bone tissue engineering strategies due to their close similarity in
size with bone tissue’s collagen fibrils (Holzwarth and Ma, 2011);
this outcome may be achieved through solution-electrospinning.
Therefore, Santocildes-Romero et al. (2016) developed composite
electrospun membranes made of a bioresorbable PCL and
particles of Sr-substituted BG, which demonstrated osteogenic
potential (Santocildes-Romero et al., 2015), and assessed their
potential for bone tissue regeneration. The electrospun fibers
exhibited porous surfaces and some regions of increased
diameter where the particles were accumulated; interestingly,
the Sr-doped BG particles were observed both inside and
on the surface of the fibers (Figure 6). The glass dissolved
after immersion in water, releasing alkaline ions that are
related to increased pH. Further evidence suggested that pH
changes is controlled or even reduced due to the accelerated
polymer degradation, which offsets the pH variation after
glass dissolution. All compositions were biocompatible in vitro
after being tested with rat osteosarcoma cells, except for the
membranes with more than 50 µg of glass on their surface
(Santocildes-Romero et al., 2016).
In another novel research, Fernandes et al. (2016) fabricated
a composite membrane by combining poly-L-lactic acid
(PLLA) with 10 wt% Sr-doped borosilicate BG (0.05Na2O–
xMgO–yCaO– (0.35-x-y)SrO−0.20B2O3−0.40SiO2 in molar
ratio, where x, y = 0.35 or 0.00, and x 6= y) using
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electrospinning. Smooth and uniform fibers (1–3µm in width)
with a homogeneous distribution of Sr-doped BG microparticles
(sizes < 45µm) were obtained. Degradation studies, performed
in phosphate buffered saline, revealed that the inclusion of
Sr-doped BG particles into the PLLA membranes accelerated
the degradability and enhanced the water uptake; furthermore,
a continuous release of cations from the glass was observed.
The addition of glass particles increased the mechanical
properties of the membranes: specifically, Young’s modulus and
tensile strength increased by about 69 and 36 %, respectively.
Additionally, cellular in vitro evaluation confirmed that the
membranes enhanced the osteogenic differentiation of BMSCs as
verified by increased ALP activity and up-regulated osteogenic
gene expression (Alpl, Sp7, and Bglap) in comparison to PLLA
alone. This study further suggests that such composites have great
potential as effective biomaterials capable of promoting bone
regeneration (Fernandes et al., 2016).
Coatings
One approach for solving the mechanical restrictions of BGs
for load-bearing applications is to apply them as a coating
on a mechanically strong and tough substrate. BG coatings
for biomedical applications were the subject of many studies
and have been comprehensively reviewed by Rawlings (1993),
Niinomi (2010), Cao and Hench (1996), Verné (2012), Xuereb
et al. (2015), Marghussian (2015), and Montazerian and Zanotto
(2016). Many promising BGs including Sr-doped BGs have
been studied to coat Ti, ZrO2, Al2O3, stainless steel, and
glass-ceramic implants. Many methods, such as enameling,
sputtering, flame spraying, laser deposition, plasma spraying,
and electrophoretic deposition (EPD), have been attempted for
application of “perfect” coatings (Verné, 2012). Sr-containing
glasses have also been utilized to develop coatings over
implants. For example, Lotfibakhshaiesh et al. (2010) were
interested in determining how SrO substitution for CaO (0,
10, 25, 50, 75, and 100%) affects sintering and crystallization
of 49.96SiO2−7.25MgO−3.30Na2O−3.30K2O−3.00ZnO−1.07
P2O5−32.62CaO (mol%) glass (Gentleman et al., 2010) coating.
Amorphous coatings on Ti-6Al-4V alloy produced by enameling
showed good adhesion to the substrate except for the 100%
Sr-substituted coating. Substituting Sr for Ca reduced the glass
transition temperature and increased the onset temperature
of crystallization. The mixed Ca/Sr glasses exhibited a larger
sintering range (i.e., the temperature range between glass
transition and crystallization), which favors glass processing
without crystallization and obtaining amorphous well-sintered
coatings. On the other hand, complete substitution led to
crystallization and reduced the temperature range for sintering
(Lotfibakhshaiesh et al., 2010). One of these resistant-to-
crystallization glasses, having thermal expansion coefficient
(TEC) similar to HA, was employed by Newman et al. (2014)
for in vivo investigations, too. The coating was applied to
roughened Ti-6Al-4V, and it produced no unfavorable tissue
reaction following implantation into the distal femur and
proximal tibia of twenty-seven New Zealand White rabbits for
6, 12, or 24 weeks. In this research, the glass dissolved over
6 weeks, stimulating enhanced peri-implant bone formation
compared with HA-coated implants in the contralateral limb
used as controls. Moreover, superior mechanical fixation was
reported in the Sr-doped BG group after 24 weeks of implantation
(Newman et al., 2014).
Miola et al. (2015) modified the original 45S5 BG
composition by introducing 6mol% of ZnO and/or SrO
in place of CaO. SEM and XRD analyses proved that Zr
and Sr addition did not significantly modify the glass
structure while EDS analysis verified the presence of these
elements in the glass composition. Sr-containing glasses
were mixed with chitosan to synthesize organic-inorganic
composite coatings on stainless steel (AISI 316L) by EPD.
Tape and bending tests revealed a good coating-substrate
adhesion for coatings made from Sr-doped 45S5 and
Zn/Sr-codoped 45S5 glasses, whereas the adherence to
the substrate decreased by using Zn-doped 45S5 glass.
Microstructural analyses showed the composite character
of coatings and indicated that the glass particles were well-
embedded into the polymeric matrix, and the coatings were
relatively uniform and crack-free. Although the bioactive
behavior of the Sr-containing coating was confirmed after
FIGURE 7 | Backscattering SEM images of a Sr-doped 45S5 glass coating after 4 weeks of implantation in the rat femur (A). A detail of the different portions of the
system is shown with arrows (B) [Adapted from Omar et al. (2015), after permission by Elsevier].
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immersion in SBF, the coatings containing Zn exhibited
no bioactivity.
Later, Omar et al. (2015) utilized another organic-inorganic
composite coating to protect the stainless-steel implant and
generate a barrier for metallic ion dissolution by using the
potential of BG particles. The composite was made by a sol-
gel method containing TEOS, methyl-triethoxysilane (MTES),
colloidal silica nanoparticles, and 45S5 BG particles in which
2mol% of CaO was substituted with SrO. The corrosion
resistance and bioactivity of the stainless steel coated with this
composite were evaluated in vitro and in vivo to analyze bone
formation. The coating system provided outstanding protection
against aggressive fluids. The formation of HA was observed
after 30 days of immersion in SBF. In vivo tests in Wistar–
Hokkaido rat femur after 4 or 8 weeks showed minor differences
in the thickness of newly formed bone observed by SEM and
noteworthy changes in bone quality. The in vivo reaction of
the coatings containing Sr-doped BG was successful in the
early stages of implantation regarding the bone morphology and
quality (Figure 7) (Omar et al., 2015).
More recently, Molino et al. (2017) developed a hierarchical
scaffold with a trabecular architecture mimicking that of
cancellous bone via EPD of Sr-doped mesoporous BG (MBG)
particles on the surface of sponge replicated strong but inert
glass-ceramic scaffold. The spherical particles of mesoporous
SiO2−CaO–SrO glass was synthesized by aerosol-assisted spray
drying that, after being deposited on the glass-ceramic scaffold
walls, stimulated a fast apatite-forming ability. Such a meso-
macroporous hierarchical implant was suggested as a bioactive
and mechanically strong implant for potential applications in
bone tissue engineering.
Glass-Ceramics
It is known that bioactive GCs are designed for at least two
main objectives: (i) improving the mechanical properties of
glasses or (ii) benefiting from a particular characteristic of
crystals (Montazerian and Zanotto, 2016). For example, needle-
like apatite in many GCs improves mechanical properties,
resembles the biological apatite in bone, and enhances the
aesthetic features of dental GCs (Montazerian and Zanotto,
2017b). In this regard, the conversion of Sr-containing glasses
into glass-ceramic in which different type of crystals, e.g., Sr-
doped phases, are crystallized would have some beneficial effects.
Therefore, (Topalovic´ et al., 2017) have developed glass-ceramics
in the 42P2O5−40CaO−5SrO−10Na2O−3TiO2 (mol%) system
through the sintering of melt-quenched glassy frits. They
neither detected a phase containing Sr nor measured mechanical
properties. However, they observed the formation of HA on
the glass-ceramic surface immersion of the GCs for 21 days in
SBF solution (Topalovic´ et al., 2017). Dessou et al. have also
reported no adverse influence on the bioactivity mechanism
after increasing Sr content which leads to the formation of
strontium silicate and Sr-doped diopside (MgCaSi2O6) in the
thermally treated gel-derived BG powder discussed in section
Sr-containing BGs: an overview (Dessou et al., 2017). We agree
with them that the new glass-ceramic can be employed for
the synthesis of Sr-containing/releasing scaffolds for bone tissue
repair or engineering. Nevertheless, to examine the kinetics of
Sr release and to provide insights into its beneficial effect on
cell attachment, proliferation differentiation, and alsomechanical
properties, further work should be conducted.
Additionally, Kapoor et al. (2013) have studied the influence
of SrO and ZnO co-dopants on thermo-mechanical behavior
of alkali-free bioactive glass-ceramics of (36.07-x)CaO–xSrO–
(19.24-y)MgO–y ZnO−5.61P2O5−38.49SiO2−0.59CaF2 (x= 2–
10, y = 2–10) (mol%). They could sinter the glass powders
before the onset of crystallization, leading to well-sintered and
mechanically strong glasses/glass-ceramics after heat treating for
1 h at 800, 850, and 900◦C. The crystalline phases of diopside
and fluorapatite [Ca5(PO4)3F] with partial replacement of Ca
for Sr with increasing strontium contents were detected in
the densified specimens (Kapoor et al., 2013). The substitution
of SrO with CaO led to the partial replacement of Ca2+ by
Sr2+ in the fluorapatite and diopside crystal structures. The
maximum flexural strength of ∼150 MPa and Weibull modulus
of ∼19 were recorded for the samples sintered at 850◦C.
In another research, Cai et al. (2011) have sintered Sr and
Mg co-doped calcium phosphate gel-glasses to prepare GCs.
XRD data revealed the presence of Ca4P6O19 and β-Ca2P2O7
for all heat-treated samples, and amorphous glass decreased
with the increase of the heat treatment temperature. A fast
release of Mg2+ ions from the residual glass was documented
in the case of the glass-ceramics obtained by heat treatment
at 700◦C. This event supports the formation of amorphous
apatite deposition. Although, the presence of Mg2+ ions in
the solution resulted in a delay in the crystallization of apatite
layer, and induced dissolution/precipitation dynamic processes
on the glass-ceramic surface and an unstable surface that
had a detrimental effect on cell attachment and proliferation
during in vitro cell culture procedure. On the contrary, less
glassy phase, and a stable apatite layer were observed in the
samples heat-treated at 760 and 780◦C, resulting in creating a
proper surface for cell growth and differentiation. Sr element,
preliminary existed in the glassy phase, was later detected in
all the deposited apatite particles on sample surface immersed
in SBF, indicating that the incorporated Sr was capable of
substituting into the apatite nuclei and favoring its crystallization.
It seems that the release of Sr2+ ions from glassy phase or
Sr-doped crystals, e.g., Ca4P6O19, in GCs offer an insight
into the choice of a sintered Sr-containing GCs for the
development of three-dimensional porous scaffolds for bone
tissue engineering. However, further focus on the effect of these
crystals on the biological and mechanical properties of GCs
are required. Table 3 summarizes different characteristics of
Sr-doped or Sr-BGs containing materials described in section
Bone cements.
THREE-DIMENSIONAL (3D) SCAFFOLDS
Sr-doped BGs have also been processed to acquire a porous
structure at different size scales (from macro- to meso-range),
thus obtaining tissue engineering 3D scaffolds allowing bone
ingrowth and regeneration.
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TABLE 3 | Physical, chemical, and biological properties of some Sr-doped or Sr-BGs containing materials described in section Bone cements.
Material type and composition Physical properties* Mechanical properties* In vitro / In vivo properties References
Sr-doped hydroxyapatite (HA) Final setting time: 15–18min
Setting temperature: max. 58◦C
Compressive strength: ∼41 MPa
Bending strength: ∼31 MPa
Elasticity modulus: ∼1.5 GPa
Improving the osteoblast adhesion
and mineralization in vitro and bone
growth and osseointegration in vivo
Cheung et al., 2005; Ni
et al., 2006
Sr-doped calcium phosphate-based
cement (CPC)
Initial and final setting of 8–10min and
∼15min, respectively
Compressive strength: ∼12 MPa Promoting cell proliferation and ALP
activity of MG-63 cells cultured on the
cement doped with Sr
Kuang et al., 2012
Series of ionomer cements containing
SiO2-ZnO–CaO–SrO based BGs
Working and setting time still have to
be adjusted
Compressive strength: 39–75 MPa
Flexural strength: 34–62 MPa
Have to be evaluated after optimizing
physical and mechanical properties
Boyd et al., 2008; Wren
et al., 2008, 2010,
2013; Clarkin et al.,
2009
CPC containing 42SiO2-4P2O5-(39-
x)CaO−15Na2O–xSrO (in mol%,
x=1.95, 3.90, 9.75, 19.5, 29.25, 39)
Final setting time: 20-40min Max. ompressive strength: 12.5 MPa Forming in vitro Sr-doped HA D’Onofrio et al., 2016
Chitosan-based cement containing
5.5Na2O−7.34K2O−7.34MgO−20.18
CaO−49.54B2O3−1.83P2O5−8.27SrO
in mol% borate BGs
Initial setting time: 12min Max. compressive strength of 19 MPa Enhancing the proliferation and
osteogenic differentiation of hBMSCs
in vitro
New bone in rat tibia after 8 weeks
Zhang et al., 2015
PMMA-based cement containing
6Na2O−8K2O−8MgO−16CaO−6SrO
−27B2O3−27SiO2−2P2O5 (mol%)
in mol% borosilicate BGs
Final setting time: 8–12min Max. compressive strength of 78–88
MPa
Flexural strength: 50–60 MPa
Elasticity modulus: ∼2.5–2.7 GPa
Promoting the adhesion, migration,
proliferation, and collagen secretion of
MC3T3-E1 cells in vitro
New bone formation in rat tibia after
8–12 weeks
Cui et al., 2017
PMMA-based cement (Spineple®)
containing
40SiO2-30Na2O−20SrO−10 CaO in
mol% BGs
Setting time: 16–18min
Setting temperature: 50–75◦C
Max. compressive strength of 75–100
MPa
Elasticity modulus: ∼2.5–2.7 GPa
– O’Brien et al., 2010
PMMA-based cement (Spineple®)
containing SiO2-CaO–P2O5-SrO
gel-derived BGs
Setting time: 16–20min
Setting temperature: ∼34–45◦C
Max. compressive strength: ∼100
MPa
Elasticity modulus: ∼1.5–2.5 GPa
– Goñi et al., 2018
*Minimum requirement set by ISO 5833 for polymeric cements:
Max. peak temperature:: 908◦C.
Setting times for operation in a surgical room 6–15 min.
Compressive strength > 70 MPa.
Flexural strength > 50 MPa.
Elasticity modulus > 1.8 GPa.
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Sr-containing BG scaffolds were first prepared by two
independent research groups from China Zhu et al. (2011) and
Japan Wang et al. (2011) in 2011 by using MBGs as starting
materials. Specifically, CaO-SrO-SiO2-P2O5 MBG scaffolds were
fabricated by the combination of polyurethane foam and
block copolymer EO20PO70EO20 (P123) as co-templates and
evaporation-induced self-assembly (EISA) process, according to
a strategy pioneered in 2007 by Li et al. (2007) for the production
of macro-mesoporous hierarchical scaffolds. These Sr-doped
MBG scaffolds exhibited an interconnected macroporous 3D
network with a pore diameter in the range of 100 to 400µm,
which closely mimicked the trabecular architecture of cancellous
bone and mesoporous walls with mesopore size of 4–5 nm.
They showed no significant difference in terms of phase
composition (being amorphous), macroporous structure, and
textural characteristics compared to the Sr-free scaffolds used as
a reference. The release of Sr2+ ions into the culture medium
was reported to enhance the proliferation and ALP activity
of mesenchymal stem cells (MSCs)(Wang et al., 2011) as well
as the osteogenic expression of MC3T3-E1 osteoblast-like cells
(Li et al., 2007).
Interestingly, the osteogenesis/cementogenesis-related gene
expression of periodontal ligaments cells (harvested from human
patients) was also observed to be stimulated by increasing
concentrations of Sr released by MBG foams, thus suggesting the
suitability of these materials for periodontal tissue engineering
applications (Wu et al., 2012). This early in vitro evidence
was further corroborated by the results from a study in an
osteoporotic animal model of bilaterally ovariectomized rats
(Zhang et al., 2014a). Specifically, Sr-doped MBG scaffolds were
reported to significantly increase alveolar bone regeneration in
the periodontium of osteoporotic rats at 1 month after surgery
(bone formation: 46.67%) as compared to the Sr-free MBG
group (39.33%) and unfilled controls (17.50%). Furthermore,
osteoclasts were significantly reduced in defects receiving Sr-
MBG scaffolds, as expected from the ability of Sr to halt bone
resorption. Analogous results about the ability of Sr-doped
MBG scaffolds to promote bone formation and reduce osteoclast
activity were reported after implanting the graft in critical-size
defects created in the femur of ovariectomized rats (osteopenic
animal model) (Zhang et al., 2013; Wei et al., 2014).
Despite the attractive textural and biological properties, MBG
foams produced by co-templating (polymeric sponge + EISA)
often suffer from a major limitation, namely high brittleness
(compressive strength about 50–250 kPa (Wu et al., 2010, 2011,
2013), which make them difficult to easily handle by surgeons
and to easily apply in clinics. Therefore, other processing
routes have been experimented to increase the mechanical
properties of MBG scaffolds to more acceptable levels for bone
repair applications. Zhang et al. (2014b) first reported the
use of 3D printing to fabricate hierarchical Sr-doped MBG
scaffolds by extruding and depositing filaments of glass powders
bound together with poly(vinyl alcohol) gel according to a
layer-wise approach (Figure 8). These scaffolds, retaining the
mesoporous texture in the glass walls along with a grid-like
macroporous structure, exhibited a compressive strength (8–9
MPa) that was about 170 times higher than that of sponge-
templated MBGs, and an excellent apatite-forming ability in
SBF. Furthermore, the fabricated samples could promote the
proliferation and differentiation of osteoblastic cells in vitro and
showed attractive properties for sustained drug release (model
drug: dexamethasone) for use in local drug delivery therapy, due
to their inherent mesoporous structure. After being implanted in
critical-size calvarial defects of rats, these 3D-printed Sr-doped
MBG scaffolds revealed superior osteoinductive properties and
pro-angiogenic ability to enhance bone formation compared to
Sr-free MBG controls (Zhao et al., 2015). On the other hand,
major general drawbacks of 3D-printedMBG scaffolds compared
to sponge-replicated ones include higher manufacturing cost
and loss of the typical bone-like trabecular architecture, which
is replaced by a more simplified grid-like array of micro-sized
channels (Baino et al., 2016).
Instead of using sol-gel MBGs, Erol et al. (2012) fabricated
macroporous SiO2-CaO-P2O5-SrO glass scaffolds by sponge
replication starting from melt-derived glass powder. These
scaffolds were bioactive, as demonstrated by the formation of
a surface HA layer after immersion in SBF, and able to act as
vehicles for the local release of therapeutic Sr2+ ions. However,
the kinetics of both apatite formation and Sr delivery were
significantly lower and less finely controllable compared to Sr-
doped MBGs, due to the absence of a mesoporous texture—
and hence a lower specific surface area (Izquierdo-Barba and
Vallet-Regí, 2015)—in melt-quenched materials. Furthermore,
the compressive strength of these Sr-containing BG foams (0.1
MPa) was one order of magnitude lower than that of cancellous
bone; some improvements (1.4 MPa) were obtained by the
coating of the scaffold struts with gelatin, which performed a
crack-bridging action. Özarslan and Yücel, 2016) produced Sr-
doped glass scaffolds by the same method using rice hull ash as
a sustainable source for SiO2 and obtained analogous results to
Erol et al. (2012).
Given its importance in the context of bone tissue engineering
scaffolds, the bioactivity mechanism of Sr-containing melt-
derived BGs was studied by Sriranganathan et al. in detail
(Sriranganathan et al., 2016). It was observed that Ca replacement
with Sr in the glass composition could retard the formation of
a HA-like phase. It was proposed that the formation of apatite
happens through an octa-calcium phosphate precursor phase,
which subsequently transforms to HA. However, the equivalent
octa-Sr phosphate does not exist, and hence, in the absence of
Ca, apatite formation does not occur.
A few studies have recently dealt with the incorporation of Sr-
doped BG particles in polymeric matrices to obtain composite
scaffolds, such as electrospun polycaprolactone fibrous meshes
(Ren et al., 2014), gelatin-based freeze-dried bone grafts (Jalise
et al., 2018; Zhao et al., 2018), and acrylic gel (Zhang et al.,
2017). In general, all these studies have emphasized the role of Sr-
containing glass inclusions to impart osteogenic and angiogenic
properties to the non-bioactive polymeric matrix. Early extrusion
tests were also performed to produce composite scaffolds by 3D
printing of type I collagen gel enriched with spray-dried SiO2-
CaO-SrO MBG submicronic spheres (Montalbano et al., 2018).
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FIGURE 8 | 3D printing of Sr-doped MBGs: (A) photograph of 3D-printed scaffolds; SEM images of the MBG scaffolds doped with (B) 0 (control), (C) 5, (D) 10, and
(E) 20mol% of Sr. Images adapted from Zhang et al. (2014b).
In a very interesting study, Zhang et al. (2017) fabricated 3D-
printed polycaprolactone/Sr-doped MBG composite scaffolds
and tackled the ambitious challenge of finding a correlation
between macroporous characteristics of the implant and
biological response of bone cells. For this purpose, three batches
of composite scaffolds were prepared in which the angles between
the latitudes and longitudes of printed filaments were set to
45, 60 and 90◦, and then the proliferation and ALP activity
of MC3T3-E1 cells were tested to assess any difference due to
macropore geometry. It was shown that the cell proliferation rate
on the 45◦-oriented scaffolds was slightly higher than that on
the other types after 1 and 4 days, but there was a significant
increase at 1 week. Furthermore, the 45◦-oriented scaffolds
were associated with a significant increase in ALP activity of
cells compared to the other groups after 2 weeks. These early
results, suggesting that an orientation of 45◦ among the scaffold
struts could be more favorable to promote cell proliferation and
osteogenic differentiation, represent an important step toward
the development of optimal scaffold design and motivate further
investigation on this topic.
Most of the available studies focus on Sr-doped silicate glasses,
produced by either melting or sol-gel-like strategies (MBGs);
however, Yin et al. (2018) recently reported the fabrication
of sponge-templated scaffolds using melt-derived borosilicate
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FIGURE 9 | Borosilicate 13-93B2 glass foam doped with 6mol% of Sr: (a) polyurethane foam used as a template; (b,c) foam-replicated scaffold; (d) apatite
agglomerates formed on the surface of the scaffold after immersion in SBF for 5 days. Images adapted from Yin et al. (2018) with permission.
glasses with high B2O3 content (13-93B2 basic composition
(18SiO2–36B2O3–22CaO–6Na2O–8K2O–8MgO–2P2O5 mol%)
doped with 3, 6, and 9mol% SrO). Borosilicate glasses are
attractive for tissue engineering applications being characterized
by higher reactivity with biological fluids—and hence faster
apatite-forming kinetics—compared to silicate glasses, but high
amounts of boron ions can be toxic to cells (Balasubramanian
et al., 2018). It was reported that Sr-doped 13-93B2 glass scaffolds
were bioactive and had suitable features for bone repair (bone-
like trabecular structure, porosity 80 vol.%, pore size 200–
500µm, compressive strength 11 MPa) (Figure 9); moreover,
very interestingly, the increase of Sr concentration in the glass
formulation accelerated the release of silicate and Ca2+ ions,
known for having a stimulatory effect on osteogenesis (Hench,
2009) and angiogenesis (Kargozar et al., 2018d), and significantly
reduced the release of boron ions in some extent. Therefore,
doping with particular proportions of SrO was suggested as a
mean to decrease or even suppress the rapid release of boron, thus
minimizing its cytotoxicity.
BIOLOGICAL FUNCTIONS OF STRONTIUM
Osteogenesis Induction
The main concept behind adding Sr to BG structure is related to
its potential of improving the proliferation and the differentiation
of pre-osteoblastic cells into osteoblasts via the activation of
various cell signaling pathways such as Ras-mitogen-activated
protein kinase (Ras/MAPK) (Peng et al., 2009). Sr can bond
to the calcium-sensing receptor (CaRS) and, thereby, activates
Ras/MAPK resulting in the up-regulation of genes involved
in osteogenesis (e.g., Runx2) (Schindeler and Little, 2006).
The activation of the NFATc1 signaling pathway is another
mechanism by which Sr2+ ions can promote osteogenesis. This
signaling pathway can up-regulateWnt3AmRNA expression and
trigger β-catenin dependent Wnt/β-catenin signaling pathway
in MSCs (Yang et al., 2011). It has been previously shown
that Wnt/β-catenin signaling plays an important role in
bone development and homeostasis as well as regulation of
the commitment of the differentiation of stem cells into
osteoblastic lineages during fracture healing (Chen et al., 2007).
Furthermore, Sr may activate the osteogenic differentiation of
MSCs through the production of cyclo-oxygenase 2 (COX-2)-
mediated prostaglandin E2 (PGE2) (Marie, 2007). Regarding
the mentioned data, several researchers worldwide investigated
the potential of Sr-containing glasses to accelerate bone repair
and regeneration. As an illustration, Santocildes-Romero et al.
prepared a series of 45S5 BGs in which Ca was partially
(50%) or fully (100%) substituted by Sr (named as Sr50
and Sr100, respectively) and evaluated the osteogenic effects
of the materials produced (Santocildes-Romero et al., 2015).
The results of real-time PCR showed that the incubation of
MSCs with 13.3 mg/mL of Sr50 and ≥6.7 mg/mL of Sr100
actually resulted in up-regulation of some specific bone-related
genes like Alpl and OCN. In another study, Lao et al. using
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FIGURE 10 | The mechanisms proposed for the action of strontium ranelate (SrR) on the bone cells. SrR can stimulate bone formation through activating some
well-known receptors such as the calcium-sensing receptor (CaSR) and increasing prostaglandin E2 (PE2) production by osteoblasts. In contrast, SrR can inhibit
bone resorption via increasing osteoprotegerin and decreasing receptor activator of nuclear factor kappa B ligand (RANK) expression by osteoblasts. Adapted from
Marie (2007) with permission.
particle-induced X-ray emission (PIXE) technique showed that
biomineralization in the defect sites of the distal epiphysis of
the femur of adult male New Zealand White rabbit implanted
with 5 wt.% Sr-containing sol-gel BGs is significantly higher
than Sr-free glasses (Lao et al., 2013). The authors concluded
that this event could be correlated with the delivery of Sr2+
ions up to several ten microns around the implanted Sr-doped
glass particles.
It is noteworthy that the osteogenic effect of Sr is dose-
dependent (Verberckmoes et al., 2003). It has been shown
that Sr at low concentrations (25–500µM) promotes the
osteogenic differentiation of cells, while it has an inverse
effect on the differentiation at high concentrations (1,000–
3,000µM). In fact, Sr at higher doses induces apoptosis via the
phosphorylation of ERK1/2 signaling molecules followed by the
downregulation of Bcl-2 and increasing the phosphorylation of
BAX (Aimaiti et al., 2017).
Osteoclastogenesis Inhibition
In addition to osteoblastogenesis, Sr plays a significant role in the
osteoclastogenesis (see Figure 10). In fact, Sr is known to reduce
osteoclast differentiation, activity, and bone resorption (Baron
and Tsouderos, 2002).
Receptor activator of nuclear factor kappa-B ligand (RANKL)
is a molecule with the ability to affect bone regeneration and
remodeling. This molecule can bind to RANK on cells of the
myeloid lineages (e.g., osteoclast precursor cells) and act as a
major factor for improving the differentiation and activation of
osteoclasts (Boyle et al., 2003). Strontium causes a reduced pre-
osteoclast differentiation into osteoclasts via down-regulating
the RANKL expression and also up-regulating its antagonist,
i.e., osteoprotegerin (OPG), Saidak and Marie (2012). Moreover,
it has been documented that Sr (as SrR formulation) at high
concentrations can stimulate apoptosis in osteoclasts through
the PKC βII pathway (Hurtel-Lemaire et al., 2009). With respect
to this evidence, (Gentleman et al., 2010) evaluated the effects
of Sr-substituted BGs on osteoblasts and osteoclasts in vitro
(Gentleman et al., 2010). They developed a series of BGs based
on SiO2−P2O5−Na2O–CaO formulation in which 0–100% of
the CaO was substituted by SrO. Their results revealed that the
release of Sr2+ ions from the glasses into cell culture medium
enhances metabolic activity in osteoblasts, whereas the activity
of osteoclasts inhibits (RAW264.7 monocytes). The last event
is approved through the reduction of tartrate-resistant acid
phosphatase activity and the inhibition of resorption of calcium
phosphate films in a dose-dependent manner. The authors stated
that the inhibition of osteoclast differentiation and disruption
of cytoskeletal elements are the two main reasons by which the
Sr-substituted glasses act.
Antibacterial Properties
The antibacterial effect of Sr has not been well-understood and
is an open issue of research. Some researchers have reported that
Sr has an inhibitory effect on various strains such as Escherichia
Coli (E. coli) and Porphyromonas gingivalis (P. gingivalis) (Zhang
et al., 2014c; Liu et al., 2016). For instance, Brauer et al. showed
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that the bactericidal action of injectable bone cements based on
BGs could be increased via Sr substitution (Brauer et al., 2012).
They reported that the samples containing small amounts of Sr
(2.5mol%) reduce the number of bacteria (Streptococcus faecalis)
up to one order of magnitude as compared to Sr-free samples.
However, the concentrations above 0.16 mmol/L (14 ppm)
exhibited no further bactericidal action. One of the mechanisms
by which Sr elicits its antibacterial activity may be attributed
to its potential to depress intracellular polysaccharide (IPS)
accumulation in bacteria such as Streptococcus mutans (Wegman
et al., 1984). It has been shown that IPS plays an important role in
the persistence of bacteria in excess sugar environments (Busuioc
et al., 2009). Another proposed mechanism for the antibacterial
effect of Sr is related to its intervention to bacterial metabolism
at concentrations above 180mM since Sr2+ ions can act as
a competitor to iron for specific binding sites in iron-sensing
proteins (Brown et al., 2006). In contrast to the studiesmentioned
above, other scientists showed that the release of increased levels
of Sr2+ has no positive effect on the bacteria inhibition (Dabsie
et al., 2009; Li et al., 2016). On this matter, Dabsie et al. showed
that Sr2+ ions have no significant antibacterial effect at the
concentrations of 0.19, 0.37, 0.74, and 1.11 mol/L. However, they
suggested that Sr2+ ions could have a synergistic effect with F−
ions in promoting the antibacterial activity.
In vitro Behavior of Sr-Containing Glasses
The biological properties of bivalent cation-doped BGs were
reviewed in details elsewhere (Cacciotti, 2017). Regardless of
the former oxides used for the design of the glass network,
several studies demonstrated that the addition of Sr into the
glass composition could promote osteoblast activity and inhibit
osteoclasts in vitro (Gentleman et al., 2010). It was shown
that Sr2+ concentrations ranging between 8.7 and 87.6 ppm
could induce a positive response of osteoblastic phenotypes
(Murphy et al., 2009). Enhanced ALP activity (Hesaraki et al.,
2010a), together with higher mineralization (Kargozar et al.,
2017) and production of ECM were also reported (Bonnelye
et al., 2008; Gentleman et al., 2010; Hesaraki et al., 2010b;
Bellucci and Cannillo, 2018). Some other studies pointed out
the beneficial effects of Sr release on cellular attachment,
proliferation (O’donnell et al., 2010) and differentiation (Isaac
et al., 2011; Strobel et al., 2013; Santocildes-Romero et al., 2015;
Stefanic et al., 2018).
It was reported that the substitution of Ca with Sr in the 45S5
glass composition led to an altered biological response in vitro,
as a result of the modifications of the physical and chemical
properties (density and solubility). Cellular metabolic activity
was critically inhibited by totally replacing Ca with Sr, but a
positive effect on mesenchymal stromal cells derived from rat
bone marrow was observed in the glass with a molar SrO/CaO
substitution of 50% (Santocildes-Romero et al., 2015).
In another study, in vitro experiments with osteosarcoma
cells revealed that 5mol% was the optimal Sr concentration
in sol-gel BGs for stimulating bone cell production of ALP
(Solgi et al., 2017).
The cytocompatibility of CaO–SrO–Na2O–ZnO–SiO2 glass
systems was compared to that of commercial Novabone R© (i.e.,
45S5 Bioglass R©), used as the control in order to evaluate
their potential as synthetic bone grafts. Cell viability assays
revealed no significantly increased cell viability when compared
to commercial control. Sr2+ concentration was found to range
between 0.8 and 38 ppm, actually in the active stimulatory
range for biomedical applications. Interestingly, it was observed
that the beneficial effect on cells was the result of a synergistic
combination of the ions dissolved in the culture medium
(Murphy et al., 2010), as enhanced proliferation was also
observed with otherwise-inactive concentrations of Ca2+ and
silicate ions only in Sr-doped systems, coherently with another
previous study (Wu et al., 2007). Comparable results in terms
of cellular proliferation were reported by Hesaraki et al., who
observed that the inclusion of SrO within the glass network
of silicophosphate glasses promoted cell proliferation and ALP
activity depending on time (Hesaraki et al., 2010b).
Naruphontjirakul et al. recently investigated the response
of MC3T3-E1 cells to BG nanoparticles (diameter 80-100 nm)
doped with different SrO amounts (Naruphontjirakul et al.,
2018). No negative effects on in vitro cell viability were observed
with up to 250µg/mL of glass, and the ionic dissolution
products were non-toxic, regardless of the concentrations.
However, concentrations of Sr-doped nanoparticles at or above
500µg/mL led to cellular death after 3 days when the direct
contact testing method was used (Naruphontjirakul et al., 2018).
This study interestingly demonstrated that the concentration
of glass nanoparticles is potentially able to affect both the
mineralization mechanism and the synthesis of new extracellular
matrix; enhanced protein expression (ALP, OSC, and OSP) and
collagen production were also observed as Sr increased both
in the nanoparticle composition and the dissolution products
(Naruphontjirakul et al., 2018).
Cytotoxicity evaluation performed byOudadesse et al. on both
Sr-doped and Sr-free glasses revealed no differences related to
the Sr addition within the network and its subsequent release in
contact with the biological environment (Oudadesse et al., 2011).
Inhibition of the pro-inflammatory response was also observed in
direct contact testing mode by exposing murine macrophages to
1 mg/mL Sr-doped MBG particles, with a significant reduction
of IL6 and IL1β expressions in MBG containing 2mol% of Sr
(Fiorilli et al., 2018).
In vivo Evaluations of Sr-Containing
Glasses
The in vivo effects of Sr-doped biomaterials in bone formation
and remodeling was exhaustively reported by Neves et al. (2017).
The in vivo bone response to Sr-containing SiO2-CaO–Na2O–
P2O5 glass particles was first reported by Gorustovich et al.
in 2009 (Gorustovich et al., 2010). This study revealed no
remarkable differences in terms of osteoconductivity with respect
to the 45S5 glass control system. In fact, the amount of Sr detected
at the interface did not alter the osteoconductive properties, and
Sr was not found in the newly-formed bone tissue.
In the same year, Boyd et al. (2009) designed a bone graft with
composition 28SrO−32ZnO−40SiO2 (mol%) and implanted it
in a standard rat femur model using healthy Wistar rats. No
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inflammatory response was detected, and the same material was
then implanted into ovariectomized rats in order to evaluate the
therapeutic potential in osteoporotic bone. The performance of
the material was found to be almost the same both in healthy and
osteoporotic bone, which was encouraging as a bone response
to implants is usually diminished in ovariectomized rats and,
therefore, suggested the great potential of such material in the
treatment of osteoporosis.
Antioxidant properties and regenerative bone capacity were
also investigated by Jebahi et al. in vivo. Sr-doped glasses were
implanted in the femoral condyles of Wistar rats; experimental
results showed a remarkable improvement in cell proliferation
and antioxidant properties against reactive oxygen species
(ROSs) due to three different mechanisms: (i) physiological bone
remodeling enhanced by the ions released which supported cells
to restore their physiological functionality and enhancement of
osteoblastic activity, responsible for the production antioxidant
species (GPx); (ii) Sr support in the elimination of oxidative
radicals, thus protecting the surrounding tissue against damage;
(iii) combined action of Sr and other ions released from the
material which contributed to restore a balanced oxidative status
(Jebahi et al., 2012).
Zhang et al. showed that Sr-incorporated MBGs scaffolds
could stimulate in vivo regeneration of osteoporotic bone defects
(Zhang et al., 2013). They implanted the scaffolds in critical-
sized femur defects in ovariectomized rats and evaluated the
bone regeneration process at time points 2, 4, and 8 weeks
post-implantation. The results revealed an enhanced new bone
formation in the animals treated with Sr-MBG scaffolds in
comparison to those treated with MBG scaffolds alone (See
Figure 11). The authors stated that Sr-MBG scaffolds could
be a promising candidate for regenerating osteoporosis-related
injuries. Moreover, O’Connell et al. (2017) observed a reduction
in the inflammatory cell infiltration, but no significant differences
in terms of neovascularization and fibrosis. These results indicate
that Sr has no effects on the normal healing process, thus
confirming the enormous potential of Sr-doped materials in
biomedical applications such as bone augmentation. However,
it is worth underlying that recent studies concern about cardiac
safety of Sr, for example, in the form of SR used currently
as a treatment for patients with osteoporosis (Donneau and
Reginster, 2014; Reginster, 2014). Although the increased risk for
cardiac events with SR was detected in randomized controlled
trials (RCTs), the situation does not appear in real life, and Sr
remains a beneficial therapeutic alternative in patients suffering
severe osteoporosis without cardiovascular contraindications,
who cannot receive another osteoporosis treatment.
CONCLUSIONS AND OUTLOOK
Using therapeutic elements released from implantable
biomaterials to efficiently and locally treat various diseases is
arising as one of the major challenges of modern bioengineering
and regenerative medicine. Sr is known to be beneficial to
patients who suffer from osteoporosis due to its capability of
promoting osteoblast function and inhibiting osteoclast activity.
Therefore, Sr incorporation in BGs may be a valuable strategy
to deliver a steady supply of Sr2+ ions to osseous defect sites in
the elderly. However, too much osteoclast inhibition may delay
bone remodeling and, hence, tissue regeneration in osteoporotic
patients. BG composition, amount of Sr incorporated and
form of application (e.g., granules, injectable cements, porous
scaffolds) are all key factors that dictate the release kinetics of
Sr2+ ions and should be taken into account while developing
FIGURE 11 | Micro-CT images from implantation of MBGs doped with 2.5 and 5% Sr in the critical femoral defect of ovariectomized rats at two, four, and 8 weeks
post-surgery. The red circle and rectangle show the boundary of the defected sites. As shown, a little new bone is present in the defects at 2 weeks, while abundant
new bone is observed at the other time points (four and 8 weeks) which depicted visible difference among the groups. Scale bar 2mm. Adapted from Zhang et al.
(2013) with permission by The Royal Society.
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potentially suitable biomaterials for the advanced treatment
of osteoporosis.
To the best of the authors’ knowledge, only
one Sr-containing glass (melt-derived StronboneTM,
44.5SiO2−4Na2O−4K2O−7.5MgO−17.8CaO−4.4P2O5−17.8SrO
mol%) achieved the market as well as clinical applications in
the form of particles and granules for dental applications
(periodontal defect filler and toothpastes) (Hill and Stevens,
2009). More recently, it was shown that Sr could be easily
incorporated in sol-gel systems, too. In this regard, MBGs
might represent the future of Sr-doped glass-based biomaterials
being able to allow the finely-controlled release of various
therapeutic metallic elements (Kargozar et al., 2018a), including
Sr. Compared to melt-derived glasses, these sol-gel materials
potentially exhibit higher versatility in terms of ion release rate,
which could ideally be tailored according to the needs of each
patient, or clinical case.
Furthermore, there is early evidence suggesting the
antibacterial potential of Sr2+ ions. The molecular mechanisms
behind the antiseptic activity of Sr should still be well-
elucidated, but this could open new horizons toward the
development of multifunctional Sr-releasing BGs able to
promote bone regeneration and prevent infections, thus
significantly accelerating the healing of bone injuries.
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